Blood markers for diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is looking at two substances in the blood of people with diabetic nephropathy to see if they can help doctors understand or track kidney disease. The goal is to improve care for people with diabetes-related kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have been diagnosed with diabetic nephropathy (kidney damage from diabetes).
- You should be currently undergoing evaluation or follow-up for diabetic kidney disease.
- You need to be able to understand and sign a consent form.
- You cannot have certain other serious conditions like liver disease, heart disease, cancer, or blood disorders.
- You cannot have had recent surgery or be taking medications that affect blood clotting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain blood markers (immune system and platelets) in people with diabetic kidney disease compared to healthy people. It may help doctors better understand and manage diabetes-related kidney damage.
This study looks at whether certain proteins in your blood can help detect kidney damage earlier in people with type 2 diabetes. It aims to find better ways to monitor kidney health and potentially prevent or delay diabetic kidney disease.
This study looks at how the bacteria in your gut and certain substances in your blood might affect blood sugar changes and kidney health in people with diabetic kidney disease. If you have type 2 diabetes and kidney issues, this trial could help find better ways to track your condition.
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
This trial is developing and checking a new technique to detect early diabetic nephropathy, which means early damage to the kidneys caused by diabetes. It may help people catch kidney problems sooner, so treatment can start earlier.
This study aims to learn more about diabetic nephropathy (kidney problems caused by diabetes) using planned kidney tissue samples. You may benefit by helping researchers understand the disease better, and you may be eligible if you already have a medically needed kidney biopsy scheduled.
Hear when a new Nephropathy, Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.